Vestibulo-otologic Events in Drug-resistant Tuberculosis Patients on Medications

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 14, Issue 7

Abstract

Aims: This study aims to document the onset, types and factors associated with vestibulo-otologic (VO) events among patients on treatment for drug resistant Tuberculosis (DRTb). Study Design: This is a prospective study of patients with drug resistant Tuberculosis who were admitted for the intensive phase of treatment with injectable medications. Place and Duration of Study: The study was carried out at drug resistant Tuberculosis (DRTb) centre, Sacred Heart Hospital, Lantoro, Abeokuta, Nigeria between October 2013 and December 2014. Methodology: Patients with complaints referable to VO effects of medications were recruited into the study. Clinical evaluation included the type, onset and duration of the vestibular or otologic events. Further information were retrieved from the patients case note records which included age, sex, retroviral status, weight on admission and height, from where the body mass index (BMI) was calculated. Data analyses were performed using SPSS version 20. Results: A total of 121 patients comprising of 80 male and 41 female patients. Modal age group distribution for all patients was the group 21-40 years (72.7%), while the mean age ±SD was 32.9±13.7 years. The duration of treatment ranged from 12 to 20 weeks, mean ±SD= 14±3.4 weeks. VO events occurred in 40.5%, vestibular events alone were in 27.3% while otologic events alone occurred in 33.1%. The VO events were noticed between 6-19 weeks of treatment (mean ±SD= 11.1±4.7 weeks). Dizziness/imbalance were the most common vestibular while tinnitus was the most common otologic event. Among the patients with VO events, 13/46=28.3%, had repeat pure tone audiometry, and 7 (15.2%) met audiometric criteria for ototoxicity. Conclusion: Vestibulo-otologic events were common among DRTb patients in Nigeria. The major complaints started around 11 weeks on medication. Factors associated with the VO events were female gender, being underweight and retroviral positive.

Authors and Affiliations

Olusola Ayodele Sogebi, Taiwo Olugbemiga Adedeji, Bolanle Olufunlola Adefuye, Susan Modupe Oladeji

Keywords

Related Articles

A Giant Pure Uterine Lipoma: A Case Report

Aims: The authors present a case of a giant pure lipoma of the uterus revealed by a postmenoposal metrorrhagia and discuss the clinical, radiological, histological characteristics and the different histogenesis hypothesi...

Knowledge of Stroke Risk Factors among Individuals Diagnosed with Hypertension and Diabetes: A Hospital-based Survey

Background: Stroke is a major cause of mortality and morbidity worldwide and primary prevention, through adequate knowledge of its risk factors and attendant risk factor control/modification, remains the best solution. T...

Chikungunya, Dengue and West Nile Virus Infections in Northern Tanzania

Aim: We aimed at determine the prevalence of Chikungunya virus (CHIKV), Dengue virus (DENV) and West Nile virus (WNV) in Bondo and Magugu wards in Handeni and Babati districts in Northern Tanzania, in a cross sectional a...

Patients’ Information Leaflets: Its’ Influence on Ophthalmic Patient Education and Medication Compliance

Aims: To investigate the influence of patient information leaflets on Ophthalmic patients’ education and medication compliance. Study Design: Hospital-based cross- sectional survey. Place and Duration of Study: Departmen...

Narratives: Discovering the Social Dimensions of Disease

Narrative research includes a variety of approaches that rely on the written or spoken word, or on the visual expressions of individuals. These approaches typically focus on individuals’ lives from the lens of their own...

Download PDF file
  • EP ID EP340469
  • DOI 10.9734/BJMMR/2016/24421
  • Views 72
  • Downloads 0

How To Cite

Olusola Ayodele Sogebi, Taiwo Olugbemiga Adedeji, Bolanle Olufunlola Adefuye, Susan Modupe Oladeji (2016). Vestibulo-otologic Events in Drug-resistant Tuberculosis Patients on Medications. Journal of Advances in Medicine and Medical Research, 14(7), 1-8. https://europub.co.uk/articles/-A-340469